desogestrel has been researched along with Obesity in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ärlemalm, A; Brynhildsen, J; Carlsson, B; Frisk, J; Ginstman, C; Hägg, S | 1 |
| Elazary, R; Elchalal, U; Levin, G; Rottenstreich, A | 1 |
| Brynhildsen, J; Ginstman, C | 1 |
| Bender, NM; Mishell, DR; Montoro, M; Najera, SO; Segall-Gutierrez, P; Stanczyk, FZ | 1 |
| Cremers, S; Davis, AR; Morrell, KM; Westhoff, CL | 1 |
| Burke, AE; McDonald-Mosley, R | 1 |
| Weisberg, E | 1 |
| Madden, T; Peipert, JF; Secura, GM; Wade, JA; Xu, H; Zhao, Q | 1 |
| Chan, LN; Gilliam, M; Martins, S; Mistretta, S; Mornar, S; Neustadt, A | 1 |
| Cremers, S; Dragoman, M; Mayeda, ER; Petrie, K; Thomas, T; Torgal, AH; Westhoff, CL | 1 |
| Cremers, S; Dragoman, M; Petrie, K; Thomas, T; Torgal, A; Westhoff, CL | 1 |
| Atlas, M; Gordon, L; Januchowski, R; Thakur, N | 1 |
| Rubio Lotvin, B | 1 |
| Fotherby, K | 1 |
1 review(s) available for desogestrel and Obesity
| Article | Year |
|---|---|
Oral contraceptives, lipids and cardiovascular disease.
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking | 1985 |
3 trial(s) available for desogestrel and Obesity
| Article | Year |
|---|---|
Plasma concentrations of etonogestrel in women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Gastric Bypass; Humans; Middle Aged; Obesity; Postoperative Period; Preoperative Period; Time Factors; Young Adult | 2019 |
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Endometrium; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation; Obesity; Ovarian Follicle; Prospective Studies; Young Adult | 2012 |
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Obesity; Ovarian Follicle; Prospective Studies; Vagina; Young Adult | 2013 |
10 other study(ies) available for desogestrel and Obesity
| Article | Year |
|---|---|
Re: Plasma concentrations of etonogestrel in obese women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
Topics: Desogestrel; Female; Gastric Bypass; Humans; Obesity; Obesity, Morbid | 2019 |
Authors' reply re: Plasma concentrations of etonogestrel in obese women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
Topics: Desogestrel; Female; Gastric Bypass; Humans; Obesity; Obesity, Morbid | 2019 |
Effects of progestin-only long-acting contraception on metabolic markers in obese women.
Topics: Animals; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Desogestrel; Fasting; Female; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intrauterine Devices, Medicated; Levonorgestrel; Metabolic Syndrome; Obesity; Progestins; Prospective Studies; Waist Circumference | 2013 |
Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Desogestrel; Drug Implants; Female; Humans; Obesity; Ovulation Inhibition; Young Adult | 2016 |
Contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Monitoring; Female; Humans; Levonorgestrel; Menorrhagia; Obesity; Pelvic Pain | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices; Obesity; Overweight; Pregnancy; Pregnancy, Unplanned; Young Adult | 2012 |
Pharmacokinetics of the etonogestrel contraceptive implant in obese women.
Topics: Adolescent; Adult; Area Under Curve; Black People; Contraceptive Agents, Female; Desogestrel; Female; Humans; Obesity; Patient Satisfaction; White People; Young Adult | 2012 |
Clinical inquiries. What hormonal contraception is most effective for obese women?
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment | 2007 |
[The desogestrel-ethinyl estradiol combination and overweight: current data].
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Obesity; Progesterone Congeners; Time Factors | 1995 |